Black Canyon Bio
Pre-clinicalSNAP uniquely enables cancer treatments to target individualized markers on a patient’s tumor called neoantigens. Our proprietary approach enables the credentialing of these neoantigens to facilitate enhanced clinical efficacy. SNAP extends promising new therapeutic approaches while overcoming key challenges, especially for treating solid tumors.
About
SNAP uniquely enables cancer treatments to target individualized markers on a patient’s tumor called neoantigens. Our proprietary approach enables the credentialing of these neoantigens to facilitate enhanced clinical efficacy. SNAP extends promising new therapeutic approaches while overcoming key challenges, especially for treating solid tumors.
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile